As 2024 draws to a close, we at Tekceleo reflect on a year filled with meaningful achievements, innovation, and global outreach. Here are some of the highlights that defined our year:
Global Presence: Showcasing Innovation at Leading Trade Fairs
- MEDICA 2024 – Düsseldorf, Germany
In November, Tekceleo participated in MEDICA 2024, the world’s premier medical trade fair. We had the opportunity to showcase our cutting-edge technologies to an international audience, demonstrating our commitment to providing innovative solutions in healthcare and pharmaceutical applications. - BIOMEDEVICE Fair in Boston and U.S. Visits
Our journey in September 2024 to the United States for the BIOMEDEVICE trade fair was another key milestone. Beyond exhibiting, we strengthened partnerships with clients and collaborators. Visits to key customers in several US States allowed us to deepen our understanding of their needs, reinforcing our dedication to delivering innovative solutions to industry demands.
Technology Breakthrough: Launching the WLG-75 at 25W
This year, we proved our capacity to reach new performances, with a proof of concept of a WLG-75 ultrasonic motor at 25W. This breakthrough represents a leap forward in ultrasonic motor technology, offering enhanced performance and efficiency for a wide range of applications, from medical devices to industrial automation. For a detailed analysis of this development, you can read our article on the design and performance of the enhanced 75 mm non-magnetic motor.
Partnership with Virexpr: Advancing Nebulization Research
2024 also marked the continuation of our strategic partnership with Virexpr, focusing on leveraging our nebulization technology to study aerosol and bioaerosol behaviors. Together, we are advancing research into contamination control, enabling breakthroughs in fields ranging from healthcare to industrial air quality solutions. Learn more about this collaboration in our article on aerosol contamination research.
Academic Contributions: A Year of Research and Discovery
This year, Tekceleo’s technologies featured in numerous research papers, further solidifying our position as a leader in piezoelectric and nebulization solutions. Notably, our Micronice nebulization technology played a crucial role in studies on acoustic drug delivery, enhancing medication delivery to the sinuses. Read more about this research in our article on acoustic drug delivery. On our motor’s range, studies from UC Berkeley highlighted a new way to add a torque sensor to our motors in an MRI environment using a SEA : Revolutionizing MRI-Guided Surgical Robots with Tekceleo’s Ultrasonic Motors and Series Elastic Actuators
Looking Ahead to 2025
As we step into 2025, we carry forward the momentum built this year. Our focus remains on driving innovation, fostering partnerships, and expanding our global reach. We are excited about the possibilities that lie ahead and are committed to delivering exceptional solutions that meet the evolving needs of our clients and industries.
We extend our deepest gratitude to our team, partners, and customers for making 2024 a remarkable year. Here’s to continued success and innovation in 2025!
